ANCOBON PRESCRIBING INFORMATION PDF

Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Zulkizshura Mogor
Country: Botswana
Language: English (Spanish)
Genre: Business
Published (Last): 28 December 2014
Pages: 402
PDF File Size: 8.78 Mb
ePub File Size: 15.61 Mb
ISBN: 143-3-52145-694-2
Downloads: 88262
Price: Free* [*Free Regsitration Required]
Uploader: Kigall

Interferon Alfa-2a, Recombinant The risk or severity of adverse effects can be increased when Interferon Alfa-2a, Recombinant is combined with Flucytosine.

Clorindione The risk or severity of bleeding can be increased when Flucytosine is combined with Clorindione. In the event of flucytosine overdosage the manufacturer recommends prompt use of gastric lavage or an emetic. Transient thrombocytopenia was noted in two other patients, one of whom also received amphotericin B.

Not indicated due to the excellent CSF: Most strains of C. Briakinumab The risk or severity of adverse effects can be increased when Flucytosine is combined with Briakinumab. Desmoteplase The risk or severity of bleeding can be increased when Desmoteplase is combined with Flucytosine.

WHO Model Prescribing Information: Drugs Used in HIV-Related Infections: Drugs: Flucytosine

The risk or severity of adverse effects can be increased when Rituximab is combined with Flucytosine. Rotavirus Vaccine The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Flucytosine. The risk or severity of bleeding can be increased when Ferulic acid is combined with Flucytosine. Idarubicin The risk or severity of adverse effects can be increased when Flucytosine is combined with Idarubicin.

  CAMBRIDGE ESSENTIAL MATHEMATICAL METHODS 3&4 PDF

The risk or severity of bleeding can be increased when Pentosan Polysulfate is combined with Flucytosine. Paclitaxel The risk or severity of adverse effects can be increased when Flucytosine is combined with Paclitaxel. The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Flucytosine. Strains initially susceptible to Ancotil may become resistant during therapy. The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Flucytosine.

The risk or severity of adverse effects can be increased when L-Phenylalanine is combined with Flucytosine. The risk or severity of neutropenia and thrombocytopenia can be increased when Diazoxide is combined with Flucytosine. Budesonide The risk or severity of adverse effects can be increased when Flucytosine is combined with Budesonide. Flucytosine may also be converted to fluorodeoxyuridylic acid, which inhibits the enzyme thymidylate synthase and disrupts DNA synthesis.

In addition, flucytosine is often given in combination with amphotericin B, which is known to adversely affect renal function in many patients. The risk or severity of adverse effects can be increased when Flucytosine is combined with Fluprednisolone.

It also appears to be an ancoboj of fungal thymidylate synthase. The risk or severity of adverse effects can be increased when Efalizumab is combined with Flucytosine.

Ancotil g/ml Solution for Infusion – Summary of Product Characteristics (SmPC) – (eMC)

The risk or severity of adverse effects can be increased when Flucytosine is combined with Gusperimus. Astaxanthin The risk or severity of bleeding can be increased when Astaxanthin is combined with Flucytosine. Vinblastine The risk or severity informatioj adverse effects can be increased when Vinblastine is combined with Flucytosine.

Bernd Baasner, Erich Klauke, “Process for the preparation of 5-fluorocytosine. The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Flucytosine.

  FAIREY CAPSTAN WINCH PDF

The risk or severity of adverse effects can be increased when Preecribing is combined with Melengestrol. The risk or severity of adverse effects can be increased when Flucytosine is combined with Halometasone.

Canakinumab The risk or severity of adverse effects can be increased when Flucytosine is combined with Canakinumab. Dicoumarol The risk or severity of bleeding can be increased when Flucytosine is combined with Dicoumarol. Adults and Children Ancotil for Anobon should be administered using a giving set.

There is contradictory evidence concerning a drug interaction between Ancotil and cytarabine. However, surgical management is the primary recommendation.

Ancotil 2.5g/250ml Solution for Infusion

Embryotoxic effects small foetus, resorption are also observed in monkeys treated with 5-fluorouracil. To email a medicine you must sign up and log in. This site uses cookies. Bosutinib The risk or severity of adverse effects informatjon be increased when Flucytosine is combined with Bosutinib.

Ancrod The risk or severity of bleeding can be increased when Ancrod is combined with Flucytosine. The risk or severity of adverse effects can be increased when Flucytosine is combined with Nelarabine. The risk or severity of adverse effects can be increased when Flucytosine is combined with Presxribing.

Colchicine The risk or severity of adverse effects can be increased when Flucytosine is combined with Colchicine. Flucytosine should only be used during pregnancy when the potential benefits justify the possible risks to the foetus. Flucytosine is not metabolized.

Categories: